Legacy Financial Advisors Inc. bought a new stake in Amrize Ltd (NYSE:AMRZ – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,580 shares of the company’s stock, valued at approximately $626,000.
A number of other institutional investors also recently modified their holdings of AMRZ. Geode Capital Management LLC bought a new position in shares of Amrize in the second quarter valued at approximately $265,000. M&T Bank Corp acquired a new position in Amrize in the second quarter worth $205,000. Arrowstreet Capital Limited Partnership acquired a new position in Amrize in the second quarter worth $3,870,000. Gabelli Funds LLC acquired a new position in Amrize in the second quarter worth $1,083,000. Finally, AXA S.A. acquired a new position in Amrize in the second quarter worth $1,065,000.
Insider Activity at Amrize
In other Amrize news, CFO Ian A. Johnston bought 4,250 shares of the business’s stock in a transaction on Tuesday, March 10th. The shares were bought at an average cost of $58.94 per share, for a total transaction of $250,495.00. Following the transaction, the chief financial officer owned 25,110 shares in the company, valued at approximately $1,479,983.40. This trade represents a 20.37% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jan Philipp Jenisch bought 60,000 shares of the business’s stock in a transaction on Friday, March 6th. The shares were acquired at an average price of $58.05 per share, for a total transaction of $3,483,000.00. Following the completion of the transaction, the chief executive officer owned 1,703,582 shares in the company, valued at approximately $98,892,935.10. This trade represents a 3.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders acquired 77,836 shares of company stock worth $4,511,449. Insiders own 0.54% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Report on AMRZ
Amrize Trading Down 2.7%
AMRZ stock opened at $50.92 on Thursday. The company has a market cap of $28.16 billion and a P/E ratio of 24.37. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The business has a fifty day moving average of $56.24 and a 200-day moving average of $55.18.
Amrize (NYSE:AMRZ – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The firm had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The firm’s quarterly revenue was up 4.7% on a year-over-year basis. As a group, equities research analysts expect that Amrize Ltd will post 2.7 EPS for the current year.
Amrize Cuts Dividend
The firm also recently announced a dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be given a dividend of $0.11 per share. The ex-dividend date is Tuesday, May 12th. Amrize’s dividend payout ratio is presently 21.05%.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
- Five stocks we like better than Amrize
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
